Head & Neck
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Head & Neck Cancer Highlights
FEATURING
Nabil Saba
- 60 views
- September 23, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Neoadjuvant Chemo Followed by Surgery & Post-Operative RT vs. Surgery & Post-Operative RT for Organ Preservation of T3 & T4a Nasal and Paranasal Sinus SCC
FEATURING
Nabil Saba
- 25 views
- September 23, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: GORTEC 2017-01 REACH Trial - Avelumab-Cetuximab-RT vs. Standards of Care in Patients With Locally Advanced SCC of Head & Neck
FEATURING
Yungan Tao
- 8 views
- September 23, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Avelumab-Cetuximab-RT vs. SoC in Locally Advanced HNSCC - Final Analysis From the REACH Trial
FEATURING
Makoto Tahara
- 51 views
- September 20, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Setanaxib + Pembro in Recurrent or Metastatic HNSCC
FEATURING
Makoto Tahara
- 25 views
- September 20, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC Post-Op CRT - Final Results of JCOG1008
FEATURING
Makoto Tahara
- 30 views
- September 20, 2024